TRYNGOLZA™ (olezarsen) Approved in U.S. for Adults...
Category : Approval/Launch 20 December 2024TRYNGOLZA shown to significantly reduce triglycerides and substantially reduce acute pancreatitis ev...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
TRYNGOLZA shown to significantly reduce triglycerides and substantially reduce acute pancreatitis ev...
Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., announced th...
Bayer announced positive topline results from the global phase III QUASAR study evaluating the effic...
Lipocine Inc., a biopharmaceutical company leveraging its proprietary technology platform to augment...
Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments...